Leukemia Cancer Market Report

Global and Region Leukemia Cancer Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：154
  • REPORT CODE：GMM1004478
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Leukemia Cancer market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Leukemia Cancermarket, defines the market attractiveness level of Leukemia Cancer market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Leukemia Cancer industry, describes the types of Leukemia Cancer market, the applications of major players and the market size, and deeply analyzes the current situation of the global Leukemia Cancer market and the development prospects and opportunities of Leukemia Cancer industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Leukemia Cancer market in Chapter 13.

    By Player:

    • Novartis

    • EISAI

    • Celgene

    • Daiichi Sankyo

    • Biogen

    • Sunesis Pharmaceuticals

    • Spectrum Pharmaceuticals

    • Takeda Oncology

    • Roche

    • GSK

    • Teva Pharmaceutical

    • Bristol-Myers Squibb

    • Pfizer

    By Type:

    • Acute Myeloid Leukaemia (AML)

    • Chronic Myeloid Leukaemia (CML)

    • Acute Lymphoblastic Leukaemia (ALL)

    • Chronic Lymphocytic Leukaemia (CLL)

    By End-User:

    • Chemotherapy

    • Radiation Therapy

    • Targeted Therapy

    • Biological Therapy

    • Stem Cell Transplant

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Leukemia Cancer Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Leukemia Cancer Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Leukemia Cancer Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Leukemia Cancer Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Leukemia Cancer Market Analysis and Outlook to 2022

    • 7.1 Global Leukemia Cancer Consumption (2017-2022)

    • 7.2 United States Leukemia Cancer Consumption (2017-2022)

    • 7.3 Europe Leukemia Cancer Consumption (2017-2022)

    • 7.4 China Leukemia Cancer Consumption (2017-2022)

    • 7.5 Japan Leukemia Cancer Consumption (2017-2022)

    • 7.6 India Leukemia Cancer Consumption (2017-2022)

    • 7.7 South Korea Leukemia Cancer Consumption (2017-2022)

    8 Region and Country-wise Leukemia Cancer Market Analysis and Outlook to 2028

    • 8.1 Global Leukemia Cancer Consumption Forecast (2022-2028)

    • 8.2 United States Leukemia Cancer Consumption Forecast (2022-2028)

    • 8.3 Europe Leukemia Cancer Consumption Forecast (2022-2028)

    • 8.4 China Leukemia Cancer Consumption Forecast (2022-2028)

    • 8.5 Japan Leukemia Cancer Consumption Forecast (2022-2028)

    • 8.6 India Leukemia Cancer Consumption Forecast (2022-2028)

    • 8.7 South Korea Leukemia Cancer Consumption Forecast (2022-2028)

    9 Global Leukemia Cancer Market Outlook by Types and Applications to 2022

    • 9.1 Global Leukemia Cancer Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Acute Myeloid Leukaemia (AML) Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Chronic Myeloid Leukaemia (CML) Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Acute Lymphoblastic Leukaemia (ALL) Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Chronic Lymphocytic Leukaemia (CLL) Consumption and Growth Rate (2017-2022)

    • 9.2 Global Leukemia Cancer Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Chemotherapy Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Radiation Therapy Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Targeted Therapy Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Biological Therapy Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Stem Cell Transplant Consumption and Growth Rate (2017-2022)

    10 Global Leukemia Cancer Market Outlook by Types and Applications to 2028

    • 10.1 Global Leukemia Cancer Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Acute Myeloid Leukaemia (AML) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Chronic Myeloid Leukaemia (CML) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Acute Lymphoblastic Leukaemia (ALL) Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global Chronic Lymphocytic Leukaemia (CLL) Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Leukemia Cancer Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Biological Therapy Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Stem Cell Transplant Consumption Forecast and Growth Rate (2022-2028)

    11 Global Leukemia Cancer Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Leukemia Cancer Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Leukemia Cancer Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Leukemia Cancer Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Leukemia Cancer Market Competitive Analysis

    • 14.1 Novartis

      • 14.1.1 Novartis Company Details

      • 14.1.2 Novartis Leukemia Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Novartis Leukemia Cancer Product and Service

    • 14.2 EISAI

      • 14.2.1 EISAI Company Details

      • 14.2.2 EISAI Leukemia Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 EISAI Leukemia Cancer Product and Service

    • 14.3 Celgene

      • 14.3.1 Celgene Company Details

      • 14.3.2 Celgene Leukemia Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Celgene Leukemia Cancer Product and Service

    • 14.4 Daiichi Sankyo

      • 14.4.1 Daiichi Sankyo Company Details

      • 14.4.2 Daiichi Sankyo Leukemia Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Daiichi Sankyo Leukemia Cancer Product and Service

    • 14.5 Biogen

      • 14.5.1 Biogen Company Details

      • 14.5.2 Biogen Leukemia Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Biogen Leukemia Cancer Product and Service

    • 14.6 Sunesis Pharmaceuticals

      • 14.6.1 Sunesis Pharmaceuticals Company Details

      • 14.6.2 Sunesis Pharmaceuticals Leukemia Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Sunesis Pharmaceuticals Leukemia Cancer Product and Service

    • 14.7 Spectrum Pharmaceuticals

      • 14.7.1 Spectrum Pharmaceuticals Company Details

      • 14.7.2 Spectrum Pharmaceuticals Leukemia Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Spectrum Pharmaceuticals Leukemia Cancer Product and Service

    • 14.8 Takeda Oncology

      • 14.8.1 Takeda Oncology Company Details

      • 14.8.2 Takeda Oncology Leukemia Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Takeda Oncology Leukemia Cancer Product and Service

    • 14.9 Roche

      • 14.9.1 Roche Company Details

      • 14.9.2 Roche Leukemia Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Roche Leukemia Cancer Product and Service

    • 14.10 GSK

      • 14.10.1 GSK Company Details

      • 14.10.2 GSK Leukemia Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 GSK Leukemia Cancer Product and Service

    • 14.11 Teva Pharmaceutical

      • 14.11.1 Teva Pharmaceutical Company Details

      • 14.11.2 Teva Pharmaceutical Leukemia Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Teva Pharmaceutical Leukemia Cancer Product and Service

    • 14.12 Bristol-Myers Squibb

      • 14.12.1 Bristol-Myers Squibb Company Details

      • 14.12.2 Bristol-Myers Squibb Leukemia Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Bristol-Myers Squibb Leukemia Cancer Product and Service

    • 14.13 Pfizer

      • 14.13.1 Pfizer Company Details

      • 14.13.2 Pfizer Leukemia Cancer Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Pfizer Leukemia Cancer Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Leukemia Cancer

    • Figure Leukemia Cancer Picture

    • Table Global Leukemia Cancer Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Leukemia Cancer Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Leukemia Cancer Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Leukemia Cancer Consumption by Country (2017-2022)

    • Figure United States Leukemia Cancer Consumption and Growth Rate (2017-2022)

    • Table Europe Leukemia Cancer Consumption and Growth Rate (2017-2022)

    • Figure China Leukemia Cancer Consumption and Growth Rate (2017-2022)

    • Figure Japan Leukemia Cancer Consumption and Growth Rate (2017-2022)

    • Figure India Leukemia Cancer Consumption and Growth Rate (2017-2022)

    • Figure South Korea Leukemia Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Leukemia Cancer Consumption Forecast by Country (2022-2028)

    • Figure United States Leukemia Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Leukemia Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Leukemia Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Leukemia Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Leukemia Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Leukemia Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Acute Myeloid Leukaemia (AML) Consumption and Growth Rate (2017-2022)

    • Figure Global Chronic Myeloid Leukaemia (CML) Consumption and Growth Rate (2017-2022)

    • Figure Global Acute Lymphoblastic Leukaemia (ALL) Consumption and Growth Rate (2017-2022)

    • Figure Global Chronic Lymphocytic Leukaemia (CLL) Consumption and Growth Rate (2017-2022)

    • Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)

    • Figure Global Radiation Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Targeted Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Biological Therapy Consumption and Growth Rate (2017-2022)

    • Figure Global Stem Cell Transplant Consumption and Growth Rate (2017-2022)

    • Figure Global Acute Myeloid Leukaemia (AML) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chronic Myeloid Leukaemia (CML) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Acute Lymphoblastic Leukaemia (ALL) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chronic Lymphocytic Leukaemia (CLL) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Targeted Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Biological Therapy Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Stem Cell Transplant Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Leukemia Cancer Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Leukemia Cancer Export by Region (Top 5 Countries) (2017-2028)

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Leukemia Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Leukemia Cancer Product and Service

    • Table EISAI (Foundation Year, Company Profile and etc.)

    • Table EISAI Leukemia Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table EISAI Leukemia Cancer Product and Service

    • Table Celgene (Foundation Year, Company Profile and etc.)

    • Table Celgene Leukemia Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Celgene Leukemia Cancer Product and Service

    • Table Daiichi Sankyo (Foundation Year, Company Profile and etc.)

    • Table Daiichi Sankyo Leukemia Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Daiichi Sankyo Leukemia Cancer Product and Service

    • Table Biogen (Foundation Year, Company Profile and etc.)

    • Table Biogen Leukemia Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Biogen Leukemia Cancer Product and Service

    • Table Sunesis Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Sunesis Pharmaceuticals Leukemia Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sunesis Pharmaceuticals Leukemia Cancer Product and Service

    • Table Spectrum Pharmaceuticals (Foundation Year, Company Profile and etc.)

    • Table Spectrum Pharmaceuticals Leukemia Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Spectrum Pharmaceuticals Leukemia Cancer Product and Service

    • Table Takeda Oncology (Foundation Year, Company Profile and etc.)

    • Table Takeda Oncology Leukemia Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Takeda Oncology Leukemia Cancer Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Leukemia Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Leukemia Cancer Product and Service

    • Table GSK (Foundation Year, Company Profile and etc.)

    • Table GSK Leukemia Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Leukemia Cancer Product and Service

    • Table Teva Pharmaceutical (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Leukemia Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Leukemia Cancer Product and Service

    • Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb Leukemia Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb Leukemia Cancer Product and Service

    • Table Pfizer (Foundation Year, Company Profile and etc.)

    • Table Pfizer Leukemia Cancer Sales, Price, Value and Gross Profit (2017-2022)

    • Table Pfizer Leukemia Cancer Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US